• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION FREESTYLE AORTIC ROOT BIOPROSTHESIS; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION FREESTYLE AORTIC ROOT BIOPROSTHESIS; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number FR995-29
Device Problems Material Erosion (1214); Hole In Material (1293)
Patient Problems Bradycardia (1751); Thrombus (2101); Pseudoaneurysm (2605); Complete Heart Block (2627)
Event Date 12/16/2014
Event Type  Injury  
Event Description
Medtronic received information that this aortic root bioprosthesis was explanted approximately 18 months after implant due to thrombus and erosion of the device wall.No device anomalies had been observed at the scheduled six-month follow-up.Approximately 12 months later, an echocardiogram showed a false aneurysm with demonstrable blood flow into it.The patient also was in complete heart block with a heart rate of 40 beats per minute (bpm).A temporary pacing wire was implanted to provide pacing support at 60 bpm.There were no signs of infection, but antibiotics were administered as a precautionary preventive measure.At explant, there were three small holes found in the device and in the native aortic wall containing the device, and clots filling the space between the device and the native tissue.The holes were unassociated with any suture line, and tests showed no evidence of infection or any organisms.A different device of the same model and size was successfully implanted.No subsequent adverse patient effects were reported.
 
Manufacturer Narrative
It was reported that the device will be returned for analysis.A supplemental report will be filed when the analysis/investigation is completed.(b)(4).
 
Manufacturer Narrative
The device has been returned for analysis.Analysis is ongoing.A supplemental report will be filed when the analysis/investigation is completed.The device history record was reviewed and showed that this product met all manufacturing specifications for product released for distribution.No issues were identified that would have impacted this event.
 
Manufacturer Narrative
Product analysis: upon receipt at medtronic's quality laboratory, visual inspection of the device indicated the sewing ring to be slightly everted.Per the instructions for use (ifu), ¿bioprosthesis implantation- take care not to evert (roll outward) the inflow end of the bioprosthesis when suturing the valve to the patient¿s annulus.Eversion could damage the valve tissue.¿ the aortic wall appeared slightly dilated.Three visible areas of ruptures, consistent for a pseudoaneurysm adjacent to all three sinus of valsalva, were present.The edges appeared rolled and smooth, suggesting ¿adventitial hemorrhage¿.The larger hole on the right sinus extended to the edge of the sewing cloth.Minor stress marks were noted on the intima where another part of the edge appears rolled.All leaflets were stiff but slightly flexible, except where host tissue extended on the outflow of the right cusp.All leaflets were intact.An intracuspal hematoma was observed on the tunica of the right cusp.All commissures were intact.A thin layer of pannus extended onto the inflow of the right cusp.A layer of tan thrombotic appearing host tissue lined the belly of the right cusp.Off-white friable, non-vegetative appearing tissue was observed on the outer wall of the valve.Radiography showed no evidence of mineralization in the valve and/or host tissue.Conclusion: product analysis indicated the right cusp was stretched where the largest hole was located.It¿s possible that the right cusp being stretched like this may have put more tension on the right cusp sinus area where the largest hole was located.The analysis also confirmed a layer of tan thrombotic host tissue lined the belly of the right cusp.Based on the received information and the returned product analysis, the definitive cause of the ruptures was unable to be determined.It has been confirmed that no infection was found.However, it cannot be ruled out whether there are any underlying inflammation responses at play for the cause.Journal articles suggest several possible contributing causes of freestyle rupture.The ozaki paper lists embryologic anatomic weakness and tension by fluid collections in the non-coronary sinus as possible causes.In one patient, the immunologic biocompatibility of the valve was questioned.Medtronic will continue to monitor field performance for similar events should they occur.Ozaki,n., hino,y., hanafusa,y., yamsahita,t., okada,k., tsukube,t., and okita,y.Perforation of the valsalva sinus after implantation of medtronic freestyle aortic bioprosthesis.The society of thoracic surgeons.82:2282-2285.2006.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FREESTYLE AORTIC ROOT BIOPROSTHESIS
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e. deere ave.
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC STRUCTURAL HEART
8200 coral sea street ne
mounds view MN 55112
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key4408360
MDR Text Key5432235
Report Number2025587-2015-00067
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P970031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative,company representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 04/06/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/12/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/09/2018
Device Model NumberFR995-29
Device Catalogue NumberFR995-29
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/03/2015
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/06/2015
Was Device Evaluated by Manufacturer? No
Date Device Manufactured01/31/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age00050 YR
-
-